About Delfa

Billions of people still suffer from every-day diseases.

One key reason? Clinical trials are broken .

Despite $120 billion spent each year, most trials are delayed due to bottlenecks like patient recruitment.

Delfa is fixing this with autonomous AI agents. We're building AI agents to automate clinical trials.

In less than a year from launch we’ve already:

• Deployed onto 300+ trials across multiple conditions
• Reached seven figures in ARR, growing 25% MoM
• Raised an oversubscribed $3.8m seed from tier-one AI investors

What You'll Do

• Design, build, and scale AI agent systems end-to-end: from voice interactions to intelligent workflow orchestration across trial sites
• Own complex projects from architecture to deployment, with real autonomy over technical decisions
• Build and evolve the infrastructure, observability, and monitoring systems need...